`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LIMITED,
`ALEMBIC PHARMACEUTICALS LIMITED, TORRENT
`PHARMACEUTICALS LIMITED, AND AMERIGEN PHARMACEUTICALS
`LIMITED
`
`Petitioner,
`
`v.
`
`UCB PHARMA GMBH
`
`Patent Owner.
`
`Case IPR2016-00510
`Patent No. 6,858,650
`
`
`
`
`
`
`CORRECTED AND UPDATED DESIGNATION OF LEAD AND
`BACKUP COUNSEL FOR JOINED PETITIONER ALEMBIC
`PHARMACEUTICALS LIMITED UNDER 37 CFR § 42.10(a)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Petitioner Mylan Pharmaceuticals Inc. and Mylan Laboratories Limited
`
`(jointly “Mylan”)1 hereby requests that lead and backup counsel for joined
`
`Petitioner Alembic Pharmaceuticals, Ltd. (“Alembic”) be updated as shown below:
`
`Lead Counsel
`
`Back-Up Counsel
`
`Manish K. Mehta
`USPTO Reg. No. 64,570
`Benesch, Friedlander,
`Coplan & Aronoff, LLP
`333 West Wacker Drive
`Chicago, Illinois 60606
`Tel: (312) 212-4953
`Fax: (312) 767-9192
`Email: mmehta@beneschlaw.com
`
`
`
`Kalpesh Shah
`USPTO Reg. No. 48,387
`Benesch, Friedlander,
`Coplan & Aronoff, LLP
`333 West Wacker Drive
`Chicago, Illinois 60606
`Tel: (312) 212-4979
`Fax: (312) 767-9192
`Email: kshah@beneschlaw.com
`
`Alembic may be served at its counsel, Benesch, Friedlander, Coplan &
`
`Aronoff, LLP, at the above-indicated email addresses.
`
`
`Date: June 14, 2017
`
`By: /s/ Mitchell G. Stockwell
`Mitchell G. Stockwell
`Registration No. 39,389
`Lead Counsel for Petitioner
`
`
`Lead Counsel
`Mitchell G. Stockwell
`
`1 Petitioner Alembic Pharmaceuticals Limited from IPR2016-01596, Torrent
`Pharmaceuticals Limited from IPR2016-01636, and Amerigen Pharmaceuticals
`Limited from IPR2016-01665 have been joined as Petitioner to this proceedings.
`
`Back-Up Counsel
`D. Clay Holloway
`
`1
`
`
`
`
`
`2
`
`Reg. No. 39,389
`mstockwell@kilpatricktownsend.com
`Kilpatrick Townsend & Stockton
`LLP
`1100 Peachtree Street, NE
`Suite 2800
`Atlanta, Georgia 30309
`(404) 815 6500
`
`Reg. No. 58,011
`cholloway@kilpatricktownsend.com
`Kilpatrick Townsend & Stockton LLP
`1100 Peachtree Street, NE
`Suite 2800
`Atlanta, Georgia 30309
`(404) 815 6500
`
`Alyson L. Wooten
`Reg. No. 58,045
`awooten@kilpatricktownsend.com
`Kilpatrick Townsend & Stockton LLP
`1100 Peachtree Street, NE
`Suite 2800
`Atlanta, Georgia 30309
`(404) 815 6500
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of CORRECTED AND
`
`UPDATED DESIGNATION OF LEAD AND BACKUP COUNSEL FOR
`
`JOINED PETITIONER ALEMBIC PHARMACEUTICALS LIMITED
`
`UNDER 37 CFR § 42.10(a) was served on June 14, 2017, by filing this document
`
`through the Patent Trial and Appeal Board End to End system, as well as
`
`delivering a copy via electronic mail upon the following attorneys of record for the
`
`Patent Owner:
`
`Jeffrey J. Oelke
`joelke@whitecase.com
`James S. Trainor, Jr.
`jtrainor@whitecase.com
`Robert E. Counihan
`rcounihan@whitecase.com
`WHITE &CASE LLP
`1155 Avenue of the Americas
`New York, NY 10036
`202-819-8200
`
`By: /s/ Mitchell G. Stockwell
`Registration No. 39,389
`Counsel for Petitioner
`
`
`
`
`Dated: June 14, 2017
`
`
`
`
`
`